Editors:
- Provides the most up-to-date data on myeloproliferative neoplasms
- Explores the role of JAK2 and MPL mutations in pathogenesis and treatment
- Gives succinct, practical coverage of conventional and investigational therapies, including transplant
- Covers current classification and WHO-based diagnostic criterion
- Includes supplementary material: sn.pub/extras
Part of the book series: Contemporary Hematology (CH)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (11 chapters)
-
Front Matter
-
Back Matter
About this book
Editors and Affiliations
-
M.D. Anderson Cancer Center, Dept. Leukemia, University of Texas, Houston, USA
Srdan Verstovsek
-
Dept. Internal Medicine, Div. Hematology, Mayo Clinic, Rochester, USA
Ayalew Tefferi
Bibliographic Information
Book Title: Myeloproliferative Neoplasms
Book Subtitle: Biology and Therapy
Editors: Srdan Verstovsek, Ayalew Tefferi
Series Title: Contemporary Hematology
DOI: https://doi.org/10.1007/978-1-60761-266-7
Publisher: Humana Totowa, NJ
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer Science+Business Media, LLC 2011
Hardcover ISBN: 978-1-60761-265-0Published: 21 October 2010
Softcover ISBN: 978-1-61779-711-8Published: 01 December 2012
eBook ISBN: 978-1-60761-266-7Published: 17 October 2010
Edition Number: 1
Number of Pages: X, 230
Topics: Hematology, Oncology, Angiology, Medical Biochemistry